Lilly Launches COVID Antibody Phase 3 Trial
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has begun a Phase 3 trial for a potential coronavirus antibody treatment. The company says the study, which is part of an ongoing collaboration with Ca... Read More
